Transgenomic Shares Slump Following Resignation of Board Chairman | GenomeWeb
NEW YORK (GenomeWeb News) – Transgenomic shares were down nearly 9 percent in mid-afternoon trading today following the company’s announcement this morning that the chairman of its board of directors, Collin D’Silva, had resigned.
 
Transgenomic shares reached a low of $.65 during the day, down 9.7 percent from their previous close of $.72.
 
D’Silva was a co-founder of Transgenomic and served as president and CEO from 1998 to 2006.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.